Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Approval for prostate cancer treatment
Breakthrough gives hope in fight against aggressive form of blood cancer
Bird flu vaccine trial shows signs of broad immune response
Base to Base biotech podcast 35: Gothenburg Tech Week, osteoarthritis and respiratory virus infections
Asabys Partners integrates Aliath Bioventures Life Sciences investment platform
PDS Biotech seeking expedited approval pathway for head and neck cancer drug
Study identifies which patients benefit most from new schizophrenia drug
Mechanism behind overactive immune cells revealed​
Investigational treatment of autosomal dominant polycystic kidney disease receives orphan drug designation